lipoatrophy risk
脂萎縮風險
diagnosing lipoatrophy
診斷脂萎縮
lipoatrophy treatment
脂萎縮治療
severe lipoatrophy
嚴重脂萎縮
lipoatrophy symptoms
脂萎縮症狀
assessing lipoatrophy
評估脂萎縮
lipoatrophy cases
脂萎縮病例
preventing lipoatrophy
預防脂萎縮
lipoatrophy onset
脂萎縮發病
early lipoatrophy
早期脂萎縮
patients with hiv often experience lipoatrophy, particularly in the face and limbs.
HIV患者常會出現脂質萎縮，尤其是在面部和四肢。
lipoatrophy can significantly impact a patient's self-esteem and body image.
脂質萎縮會顯著影響患者的自尊心和身體形象。
the development of lipoatrophy is a known side effect of long-term protease inhibitor use.
脂質萎縮的發展是長期使用蛋白酶抑制劑已知的副作用。
early detection of lipoatrophy allows for proactive management and potential interventions.
早期發現脂質萎縮可讓患者進行主動管理並採取潛在的干預措施。
lipoatrophy treatment options include lifestyle modifications and pharmacological interventions.
脂質萎縮的治療選項包括生活方式的調整和藥物干預。
severe lipoatrophy can lead to metabolic complications and other health issues.
嚴重的脂質萎縮可能導致代謝併發症和其他健康問題。
researchers are investigating the underlying mechanisms of lipoatrophy to develop targeted therapies.
研究人員正在調查脂質萎縮的潛在機制，以開發針對性的療法。
lipoatrophy presents a significant challenge in managing hiv-related complications.
脂質萎縮在管理與HIV相關的併發症方面是一個重大挑戰。
the incidence of lipoatrophy has decreased with the introduction of newer antiretroviral drugs.
隨著新型抗 retroviral 藥物的引入，脂質萎縮的發生率已下降。
monitoring for lipoatrophy is a crucial part of hiv patient care.
監測脂質萎縮是HIV患者護理的重要部分。
lipoatrophy can manifest as facial wasting and limb contour changes.
脂質萎縮可能表現為面部萎縮和四肢輪廓的改變。
lipoatrophy risk
脂萎縮風險
diagnosing lipoatrophy
診斷脂萎縮
lipoatrophy treatment
脂萎縮治療
severe lipoatrophy
嚴重脂萎縮
lipoatrophy symptoms
脂萎縮症狀
assessing lipoatrophy
評估脂萎縮
lipoatrophy cases
脂萎縮病例
preventing lipoatrophy
預防脂萎縮
lipoatrophy onset
脂萎縮發病
early lipoatrophy
早期脂萎縮
patients with hiv often experience lipoatrophy, particularly in the face and limbs.
HIV患者常會出現脂質萎縮，尤其是在面部和四肢。
lipoatrophy can significantly impact a patient's self-esteem and body image.
脂質萎縮會顯著影響患者的自尊心和身體形象。
the development of lipoatrophy is a known side effect of long-term protease inhibitor use.
脂質萎縮的發展是長期使用蛋白酶抑制劑已知的副作用。
early detection of lipoatrophy allows for proactive management and potential interventions.
早期發現脂質萎縮可讓患者進行主動管理並採取潛在的干預措施。
lipoatrophy treatment options include lifestyle modifications and pharmacological interventions.
脂質萎縮的治療選項包括生活方式的調整和藥物干預。
severe lipoatrophy can lead to metabolic complications and other health issues.
嚴重的脂質萎縮可能導致代謝併發症和其他健康問題。
researchers are investigating the underlying mechanisms of lipoatrophy to develop targeted therapies.
研究人員正在調查脂質萎縮的潛在機制，以開發針對性的療法。
lipoatrophy presents a significant challenge in managing hiv-related complications.
脂質萎縮在管理與HIV相關的併發症方面是一個重大挑戰。
the incidence of lipoatrophy has decreased with the introduction of newer antiretroviral drugs.
隨著新型抗 retroviral 藥物的引入，脂質萎縮的發生率已下降。
monitoring for lipoatrophy is a crucial part of hiv patient care.
監測脂質萎縮是HIV患者護理的重要部分。
lipoatrophy can manifest as facial wasting and limb contour changes.
脂質萎縮可能表現為面部萎縮和四肢輪廓的改變。
探索常見搜尋詞彙